1015 / 1138
Multicentric phase II
Lille, Nancy & Nice
Patients
N = 56
Sex n (%)
M
43 ( 75.4)
F
14 ( 24.6)
Age,
60 (42 – 80)
0
20
40
60
80
Percent
15 20 25 30 35 40 45 50 55 60 65 70
Duration Cetux (days)
Dose and duration
N=56
Duration (days)
Median (range)
28 (15-70)
Total dose cycle 1 (mg/m²)
Median (range)
400 (307-426)
0
20
40
60
80
Percent
500
1000
1500
2000
2500
Total Dose Cetuximab (mgm2)
77 % response at 3 months